News FDA holds back MSD’s chronic cough drug again MSD will have to return to the drawing board to chart a course for US approval of its chronic cough treatment gefapixant.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
